Indinavir how supplied

Jump to navigation Jump to search
Indinavir
CRIXIVAN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]

How Supplied

CRIXIVAN Capsules are supplied as follows:

No. 3755 — 100 mg capsules: semi-translucent white capsules coded "CRIXIVAN™ 100 mg" in green. Available as:

NDC 0006-0570-62 unit-of-use bottles of 180 (with desiccant).

No. 3756 — 200 mg capsules: semi-translucent white capsules coded "CRIXIVAN™ 200 mg" in blue. Available as:

NDC 0006-0571-43 unit-of-use bottles of 360 (with desiccant).

No. 3758 — 400 mg capsules: semi-translucent white capsules coded "CRIXIVAN™ 400 mg" in green. Available as:

NDC 0006-0573-40 unit-of-use bottles of 120 (with desiccant) NDC 0006-0573-62 unit-of-use bottles of 180 (with desiccant) NDC 0006-0573-54 unit-of-use bottles of 90 (with desiccant)

Storage

Bottles: Store in a tightly-closed container at room temperature, 15-30°C (59-86°F). Protect from moisture.

CRIXIVAN Capsules are sensitive to moisture. CRIXIVAN should be dispensed and stored in the original container. The desiccant should remain in the original bottle.[1]

References

  1. "CRIXIVAN (INDINAVIR SULFATE) CAPSULE [MERCK SHARP & DOHME CORP.]". Text " accessdate" ignored (help)

Adapted from the FDA Package Insert.